20/20 Biolabs, Inc. AIDX
0.23 USD 0.00 (-0.04%)
At closeNov 3, 2026, 4:42 PM EST
0.25 +0.02 +6.43%
After hours · Nov 3, 4:42 PM ET
0.223 Day range 0.2535
0.21 52-week range 50.00
- YTD
- -99.02%
- 1 year
- -99.02%
- Market cap
- 3.00M
- EPS (ttm)
- -0.75
- YTD return
- -99.02%
- 1-year return
- -99.02%
- Volume
- 428.18K
- Avg volume
- 101.20K
- Open
- 0.235
- Previous close
- 0.235
- Day's range
- 0.223 – 0.2535
- 52-week range
- 0.21 – 50.00
YTD -23.6049 (-98.97%)
Financials — quick view
AIDX Revenue — quarterly 730.57K
AIDX Net income — quarterly -1.51M
AIDX EPS — quarterly -0.26
News
20/20 BioLabs to Host November 4 Investor Webinar on OneTest™ Commercial Expansion and Growth Strategy 
20/20 Biolabs (NASDAQ:AIDX) and P3 Health Partners (NASDAQ:PIII) Head-To-Head Review 
12 Health Care Stocks Moving In Thursday's After-Market Session 
12 Health Care Stocks Moving In Friday's After-Market Session 
20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026 
20/20 Biolabs Inc (NASDAQ:AIDX) Stock Short Interest Declines 50.4% 
20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model - 12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session 
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
Your note
Sign in to keep a note on AIDX — it syncs with the Stock Master app.